Ann: Half Yearly Results Timing & Investor Update Call, page-59

"my question which is unlikely to be asked:

why can’t we sign a deal?"

It's a question that's on all our minds. I sent an email to them re: life science and CET:

Here's my life science question/concern:

"This is more of a concern than a question:

The company is failing to commercialize the life science division. The life science KPI's all failed to get met.
At the AGM we heard there were commercial negotiations with one life science company, a particle manufacturer, and a vaccine manufacturer.
How close is the company to securing a commercial contract with at least one company? or is the life science division dead?
sounds to me like the companies out there love our technology. They just don't want to pay for it. Exception being the one off order from SI.

Looking at the investor update a year ago, the company had high hopes of securing multiple commercial life science deals long before now."